SIRNAOMICS-B (02257) has completed the issuance of a total of 2.4356 million subscription shares, raising approximately HKD 11.3 million.

date
17:01 12/08/2026
avatar
GMT Eight
Saint Noble Pharmaceuticals-B (02257) announced that all the conditions precedent for the subscription agreement have been fulfilled, and the subscription has been completed on August 12, 2026. A total of 2,435,600 subscription shares (representing approximately 2.17% of the issued shares immediately following completion) have been allotted and issued to the subscribers at a subscription price of HKD 4.69 per share in accordance with the terms and conditions of the subscription agreement. The net proceeds from the subscription amount to approximately HKD 11.3 million. The Group intends to use the proceeds from the subscription for its general working capital.
SIRNAOMICS-B (02257) announced that all conditions precedent for the subscription agreement have been fulfilled, and the subscription has been completed on August 12, 2026. A total of 2,435,600 subscription shares (representing approximately 2.17% of the issued shares immediately after completion) have been allotted and issued to the subscriber at the subscription price of HK$4.69 per share, in accordance with the terms and conditions of the subscription agreement. The net proceeds from the subscription amount to approximately HK$11.3 million. The Group intends to use the net proceeds from the subscription for its general working capital.